[1]
., C. et al. 2022. Nodular Lymphocytic Predominant Hodgkin Lymphoma (NLPHL); Treatment Outcome Study in a Tertiary Care Cancer Hospital in Pakistan: Nodular Lymphocytic Predo-Minant Hodgkin Lymphoma. Pakistan Armed Forces Medical Journal. 72, 2 (May 2022), 599–603. DOI:https://doi.org/10.51253/pafmj.v72i2.3615.